logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 10 of 10 Items
Showing 1 - 10 of 10 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India

Dhakulkar S, Das M, Sutar N, Oswal V, Shah D,  et al.
2021-02-18 • PLOS One
2021-02-18 • PLOS One
BACKGROUND
Childhood and adolescent drug-resistant TB (DR-TB) is one of the neglected infectious diseases. Limited evidence exists around programmatic outcomes of children and adoles...
Journal Article
|
Research

Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study

Das M, Mathur T, Ravi S, Meneguim A, Iyer AS,  et al.
2021-03-10 • PLOS One
2021-03-10 • PLOS One
Background: Childhood multidrug-resistant TB (MDR-TB) still affects around 25000 children every year across the globe. Though the treatment success rates for drug-resistant TB (DR-TB) in...
Conference Material
|
Slide Presentation

Understanding the challenges faced by children, adolescents, and their caregivers during the treatment journey for drug-resistant tuberculosis: qualitative study, Mumbai, India

Das M, Mathur T, Ravi S, Meneguim A, Iyer AS,  et al.
2021-05-19 • MSF Scientific Days International 2021: Research
2021-05-19 • MSF Scientific Days International 2021: Research
Journal Article
|
Research

One step forward: successful end-of-treatment outcomes of patients with drug-resistant tuberculosis who received concomitant bedaquiline and delamanid in Mumbai, India

Das M, Dalal A, Laxmeshwar C, Ravi S, Mamnoon F,  et al.
2021-11-02 • Clinical Infectious Diseases
2021-11-02 • Clinical Infectious Diseases
BACKGROUND
The Médecins Sans Frontières clinic in Mumbai, India, has been providing concomitant bedaquiline (BDQ) and delamanid (DLM) in treatment regimen for patients with drug-resi...
Journal Article
|
Letter

Adapting TB services during the COVID-19 pandemic in Mumbai, India

Meneguim A, Rebello L, Das M, Ravi S, Mathur T,  et al.
2020-10-01 • International Journal of Tuberculosis and Lung Disease
2020-10-01 • International Journal of Tuberculosis and Lung Disease
Conference Material
|
Abstract

Challenging experiences of children, adolescents, and their caregivers during the treatment journey for drug-resistant tuberculosis: qualitative study, Mumbai, India

Das M, Mathur T, Ravi S, Meneguim A, Iyer AS,  et al.
2021-05-19 • MSF Scientific Days International 2021: Research
2021-05-19 • MSF Scientific Days International 2021: Research
INTRODUCTION
Drug-resistant TB (DR-TB) still affects around 25,000 children every year worldwide. Although treatment success rates for DR-TB in children are higher than in adults, ch...
Journal Article
|
Research

One step forward: Successful end-of-treatment outcomes of drug-resistant TB patients who received concomitant bedaquiline and delamanid in Mumbai, India

Das M, Dalal A, Laxmeshwar C, Ravi S, Mamnoon F,  et al.
2020-10-20 • Clinical Infectious Diseases
2020-10-20 • Clinical Infectious Diseases
Background
Médecins Sans Frontières clinic in Mumbai, India has been providing concomitant Bedaquiline (BDQ) and Delamanid (DLM) in treatment regimen for patients with drug-resistan...
Journal Article
|
Research

New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India

Das M, Mamnoon F, Mansoor H, Meneguim A, Singh P,  et al.
2020-12-01 • International Journal of Tuberculosis and Lung Disease
2020-12-01 • International Journal of Tuberculosis and Lung Disease
SETTING: Médecins Sans Frontières (MSF) clinic in Mumbai, India.

OBJECTIVE: To determine the final treatment outcomes, culture conversion and adverse events (AEs) during treat...
Conference Material
|
Abstract

Photovoice: addressing stigma among people living with drug-resistant tuberculosis in India

Mahbub T, Mathur T, Holmgren J, Ravi S, Das M,  et al.
2021-05-20 • MSF Scientific Days International 2021: Innovation
2021-05-20 • MSF Scientific Days International 2021: Innovation
WHAT CHALLENGE OR OPPORTUNITY DID YOU TRY TO ADDRESS? WERE EXISTING SOLUTIONS NOT AVAILABLE OR NOT GOOD ENOUGH?
Individuals with multidrug resistant tuberculosis (MDR-TB) undergo on...
Conference Material
|
Slide Presentation

Photovoice: addressing stigma among people living with drug-resistant tuberculosis in India

Mahbub T, Mathur T, Holmgren J, Ravi S, Das M,  et al.
2021-05-20 • MSF Scientific Days International 2021: Innovation
2021-05-20 • MSF Scientific Days International 2021: Innovation